Our previous studies found that HTNV-specific CD8+ T cells could provide protective immunity for viral clearance both in HFRS patients and in animal infection models (Ma et al., 2016; Tang et al., 2017; Ma et al., 2020). This evidence concerns the gene CD8A and hemorrhagic fever with renal syndrome.